Leaking Inhaler Valve Leads to Recall of Six Batches of Cipla’s Albuterol
There is a risk the inhaler wouldn’t provide the right dose.
Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021. Albuterol is used treat patients with asthma and chronic obstructive pulmonary disease.
The recall is being made because of damage to a single inhaler (Batch Number - IB20056), where leakage was observed through the inhaler valve. There is a risk the inhaler wouldn’t provide the right dose.
The product is packaged in 17 ml plain aluminum aerosol canister integrated with dose counter coupled with plastic actuator and dust cap. The recalled product has NDC code of NDC-69097-142-60 and had an expiration date of November 2023. A list of the batch numbers can be found here.
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More
